-
Several important achievements focus on recent advances in hepatitis C research!
Time of Update: 2020-10-14
Doi:10.7554/eLife.44436 In a recent study published in the international journal eLife, scientists from Princeton University said small differences in liver cell proteins in mice and human bodies may have a significant effect on the replication of HCV, which may have helped develop models of mice infected with HCV.
-
JCI insight: Research reveals the mechanism of COVID19 antibody response.
Time of Update: 2020-10-14
the study, published in the journal JCI Insight, helped to deepen understanding of the virus and the immune response associated with infection.
McAndrews et al, Heterogeneous antibodies st SARS-CoV-2 spike receptor binding domain and nucleocapsid with accounts for COVID-19 i i, JCI Insight (2020).
-
Immunity: A new approach to the development of yellow virus vaccines.
Time of Update: 2020-10-14
. Bhattacharya, said, "We wanted to study how the immune system and antibody responses were treated for different types of yellow virus infections.
the vaccine is designed to stimulate the immune response and encourage plasma and memory B cells to produce antibodies against the virus.
-
Nat Immunol: Transcription factor BATF3 improves CD8-T cell survival and immune memory.
Time of Update: 2020-10-14
In this study, we identified a transcription factor---BATF3, which very specifically regulates the survival of these cells and their transition to memory response," said Kastenmueller, who introduced the main findings of his study.
-
Commun Biol: The new study challenges the existing pattern of diabetes research.
Time of Update: 2020-10-14
, the most common model of diabetes disease has destroyed insulin-producing cells in the pancreas by using the toxic compound STZ.
used in basic research or as a means of evaluating anti-diabetic drugs, the new study could significantly affect the application and interpretation of this widely used model.
-
A list of recent research advances in the journal Science on the new coronavirus SARS-CoV-2/COVID-19 (No. 4)
Time of Update: 2020-10-14
1.Science: Revealing the presence of three different immune responses in patients with severe COVID-19 Doi:10.1126/science.abc8511 In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania in the United States found three different immune responses to SARS-CoV-2 infections, which may help predict the trajectory of the disease in patients with severe COVID-19 and may ultimately provide information on how best to treat them.
-
New research could help test vaccine effectiveness.
Time of Update: 2020-10-14
producing enough protein is essentially the first step in developing potential vaccine components," said Dr. Mittelstädt, a research and research executive.
the test will provide us with more information about the usefulness of protein fragments," said Dr. Mittelstädt, a research executive.
-
Biomaterials: Cell therapy is used to treat enteritis.
Time of Update: 2020-10-14
While stem cells have the potential to treat these inflammatory diseases in these trials, there are still problems, such as how to quickly remove cells from the body, the risk of tumor occurrence, or their ability to release therapeutic substances, so new technical solutions must be sought.
-
Research reveals new mechanisms for suppressing plant immunity.
Time of Update: 2020-10-14
In addition, the effect subproteins RipaA and RipP1 can be identified by plant NLR to produce disease-resistant reactions, but in crop production, no fully resistant varieties (e.g. tomatoes) that inhibit ETI reactions have been found, and the study found that RipAC was able to suppress this reaction.
-
Nat Metabol: Scientists have identified new inflammatory genes that could help develop new measures to reduce the risk of obesity in the population.
Time of Update: 2020-10-14
Oct 6, 2020 // -- In a recent study published in the international journal Nature Metabolism, scientists from the University of Queensland and others found that a specific gene that helps control inflammation in the body may increase the risk of obesity in individuals, effectively blocking weight gain in mice after being turned off for expression.
-
Regenerative meta: The initial clinical results of the new coronary and antibody therapy were more effective in those with insufficient immune response.
Time of Update: 2020-10-14
REGN-COV2 was more effective in serologically negative patients, with an average reduction of 0.60 log10 copies/ml of viral load in patients receiving high doses compared to the placebo group.
-
A list of recent research advances in cell journal for the new coronavirus SARS-CoV-2/COVID-19 (No. 5)
Time of Update: 2020-10-14
2.Cell: Highly effective antibodies against the new coronavirus have been identified to protect infected hamsters from lung lesions doi:10.1016/j.cell.2020.09.049 The new coronavirus SARS-CoV-2, which causes coronavirus disease (COVID-19) in 2019, is now raging around the world.
-
A list of recent research advances in cell journal for the new coronavirus SARS-CoV-2/COVID-19 (No. 4)
Time of Update: 2020-10-14
5.Cell: Single dose of ChAd vaccine protects upper and lower respiratory tracts from SARS-CoV-2 infection doi:10.1016/j.cell.2020.08.0 26 In a new study, researchers from the University of Washington's St. Louis School of Medicine developed a vaccine for the SARS-CoV-2 virus, known as ChAd, that can be effectively prevented in mice sensitive to the new coronavirus through a nose injection.
-
A list of recent research advances in the journal Science on the new coronavirus SARS-CoV-2/COVID-19 (No. 5)
Time of Update: 2020-10-14
, 2020 //--- Since December 8, 2019, several cases of pneumonia of unknown origin have been reported in Wuhan, Hubei Province, China. most patients work or live near the local South China Seafood Who
-
Cancer Res: Apoptosis inhibitors may promote the tolerance of certain lymphomas to a variety of therapies.
Time of Update: 2020-10-14
'In this study, we delved into the formation mechanisms of lymphoma and its patterns of resistance to immunotherapy, which induces apoptosis in cancer cells by combining the expression of CD40-mediated Fass with the use of IAP inhibitors or BET inhibitors against Livin's specific targeting effects, perhaps as a potential immunotherapy strategy to target the killing of malignant B-cell lymphoma and other refractic tumors,' the researchers said.
-
AJCN: What's new! A balanced intake of carbohydrates and fats may help prevent obesity, diabetes and other metabolic diseases.
Time of Update: 2020-10-14
6, 2020 // -- In a recent study published in the international journal The American Journal of Clinical Nutrition, scientists from the Agricultural Research Service of the U.S. Department of Agriculture and others found that high levels of carbohydrate intake may help regulate the expression of specific genes in the body, helping to reduce an individual's risk of obesity, high blood pressure, type 2 diabetes and other metabolic diseases.
-
Genetic mutations and immune ghosts lead to new coronary disease? Two Science papers reveal new ideas for treatment.
Time of Update: 2020-10-14
Two papers published online in science, a leading academic journal, reveal the unexpected reasons behind the new coronary disease: more than 10% of the new coronary diseases originate from the "inner ghost" of their own immune systems, and 3.5% of the severe cases are due to specific genetic mutations...
-
New oral JAK inhibitors! Pacritinib application for listing: Treatment of bone marrow fibrosis patients with severe plate plate plate reduction!
Time of Update: 2020-10-14
September 30, 2020 // -- CTI Biopharmaceuticals has announced that it has reached an agreement with the FDA to submit a new drug application following a recent pre-NDA meeting with the U.S. Food and D
-
PLOS Med: Research reveals that loss of smell is one of the symptoms of COVID19.
Time of Update: 2020-10-14
October 3, 2020 /--- -- Four out of five people who test positive for COVID-19 antibodies have lost their sense of smell and/or taste, according to a new study by Professor Rachel Batterham of the University of London on PLOS Medicine.
-
JAHA: Taking blood pressure-lowering medications can help reduce the risk of death from influenza pneumonia.
Time of Update: 2020-10-14
Oct 4, 2020 /--- According to a recent study, drugs that lower blood pressure, especially ACE inhibitors or angiotensin II blockers, can reduce mortality from influenza and pneumonia. this is the mai
